Sarepta Therapeutics | SRPT - Market Capitalization


Sarepta Therapeutics reported $1.53B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 209.65B 14.21B Aug/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.58B 712M Aug/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Eli Lilly USD 1.09T 37.2B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
Insmed USD 35.3B 1.82B Mar/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 143.89B 5.44B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 1.54B 747M Aug/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Vertex Pharmaceuticals USD 121.59B 4.48B Aug/2026